Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use

Allergy. 2020 Apr;75(4):942-946. doi: 10.1111/all.14048. Epub 2019 Oct 2.
No abstract available

Keywords: asthma; asthma treatment; biologics; eosinophils.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Humans
  • Omalizumab / therapeutic use
  • Pulmonary Eosinophilia*

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • mepolizumab